{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:10Z","timestamp":1789015690760,"version":"build-2803163510"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,11,22]]},"abstract":"<jats:p>This Study Participant\u2019s Bill of Rights is a call to action for researchers in Alzheimer\u2019s disease and related dementias (ADRD) to proactively design clinical studies that provide the option for research participants to learn their individual research results if they choose, and in a manner that ensures study integrity. This Bill of Rights was crafted by a committee of study participants, care partners, representatives of dementia advocacy organizations, and other stakeholders in dementia research for the Advisory Group on Risk Education for Dementia (AGREEDementia). The framework developed by the Multi-Regional Clinical Trials (MRCT) Return of Individual Research Results provides a useful context for researchers to plan their studies and disclosure.<\/jats:p>","DOI":"10.3233\/jad-220810","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T11:46:13Z","timestamp":1666093573000},"page":"945-952","source":"Crossref","is-referenced-by-count":34,"title":["Disclosing Individual Results in Dementia Research: A Proposed Study Participant\u2019s Bill of Rights"],"prefix":"10.1177","volume":"90","author":[{"given":"Sarah","family":"Walter","sequence":"first","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute, University of Southern California, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Taylor","sequence":"additional","affiliation":[{"name":"Lewy Body Dementia Association, Lilburn, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Tyrone","sequence":"additional","affiliation":[{"name":"Advisory Group on Risk Evidence Education for Dementia Stakeholder and Patient Sub-Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Langer","sequence":"additional","affiliation":[{"name":"Advisory Group on Risk Evidence Education for Dementia Stakeholder and Patient Sub-Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Richard","family":"Pagan","sequence":"additional","affiliation":[{"name":"Advisory Group on Risk Evidence Education for Dementia Stakeholder and Patient Sub-Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Huling","family":"Hummel","sequence":"additional","affiliation":[{"name":"Advisory Group on Risk Evidence Education for Dementia Stakeholder and Patient Sub-Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie M.","family":"Wheaton","sequence":"additional","affiliation":[{"name":"Advisory Group on Risk Evidence Education for Dementia Stakeholder and Patient Sub-Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris T.","family":"Zallen","sequence":"additional","affiliation":[{"name":"Virginia Tech, Blacksburg, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson C.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Palo Alto VAMC, Palo Alto, CA, USA"},{"name":"Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220810_ref1","doi-asserted-by":"crossref","first-page":"e12213","DOI":"10.1002\/trc2.12213","article-title":"Disclosure of individual research results at federally funded Alzheimer\u2019s Disease Research Centers","volume":"7","author":"Roberts","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220810_ref2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jalz.2012.09.014","article-title":"Disclosure of amyloid imaging results to research participants: Has the time come","volume":"9","author":"Lingler","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220810_ref4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1748-720X.2008.00270.x","article-title":"Understanding incidental findings in the context of genetics and genomics","volume":"36","author":"Cho","year":"2008","journal-title":"J Law Med Ethics"},{"key":"10.3233\/JAD-220810_ref5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/gim.2012.10","article-title":"The legal risks of returning results of genomics research.","volume":"14","author":"Clayton","year":"2012","journal-title":"Genet Med"},{"key":"10.3233\/JAD-220810_ref6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jamaneurol.2022.1307","article-title":"Disclosing Alzheimer disease biomarker results to research participants","volume":"79","author":"Grill","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220810_ref8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/JAD-151072","article-title":"Attitudes and perceptions of research in aging and dementia in an urban minority population","volume":"53","author":"Neugroschl","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220810_ref9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/jamaneurol.2021.2941","article-title":"Building inclusive and open Alzheimer disease and Alzheimer disease-related dementias research programs","volume":"78","author":"Elliott","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220810_ref10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-220458","article-title":"The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and open to all","volume":"90","author":"Rosen","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220810_ref13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifyingtherapeutic trials: Recommendations from the Alzheimer\u2019s AssociationResearch Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220810_ref14","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12756"},{"key":"10.3233\/JAD-220810_ref15","first-page":"e106","article-title":"Update on appropriate use criteria for amyloid PET imaging:Dementia experts, mild cognitive impairment, and education. AmyloidImaging Task Force of the Alzheimer\u2019s Association and Society forNuclear Medicine and Molecular Imaging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220810_ref16","first-page":"693","article-title":"\u201cFrom victimhood to warriors\u201d: Super-researchers\u2019 insights into Alzheimer\u2019s disease clinical trial participation motivations","volume":"60","author":"Bardach","year":"2020","journal-title":"Gerontologist"},{"key":"10.3233\/JAD-220810_ref17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.162.13.1457","article-title":"The debate over research on stored biological samples: What do sources think","volume":"162","author":"Wendler","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-220810_ref18","first-page":"125","article-title":"Ethical issues in the development of readiness cohorts in Alzheimer\u2019s disease research","volume":"4","author":"Milne","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220810_ref19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41591-022-01875-3","article-title":"Comorbidities confound Alzheimer\u2019s blood tests","volume":"28","author":"Schindler","year":"2022","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220810_ref20","doi-asserted-by":"crossref","first-page":"e0229137","DOI":"10.1371\/journal.pone.0229137","article-title":"Cognitively unimpaired adults\u2019 reactions to disclosure of amyloid PET scan results","volume":"15","author":"Largent","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220810_ref21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hast.452","article-title":"When should genome researchers disclose misattributed parentage","volume":"45","author":"Mandava","year":"2015","journal-title":"Hastings Cent Rep"},{"key":"10.3233\/JAD-220810_ref23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trci.2015.12.001","article-title":"A survey of knowledge and views concerning genetic and amyloid PET status disclosure","volume":"2","author":"Ott","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220810_ref24","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1371\/journal.pmed.0050091","article-title":"Communicating the results of clinical research to participants: Attitudes, practices, and future directions","volume":"5","author":"Shalowitz","year":"2008","journal-title":"PLoS Med"},{"key":"10.3233\/JAD-220810_ref25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220810_ref26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.3233\/JAD-220810_ref27","first-page":"115","article-title":"Preferences for disclosure of biomarker and genetic results in Alzheimer\u2019s research: Feedback from a participant advisory board","volume":"8","author":"Walter","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220810_ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/13607863.2017.1317334","article-title":"Alzheimer Europe\u2019s position on involving people with dementia in research through PPI (patient and public involvement)","volume":"22","author":"Gove","year":"2018","journal-title":"Aging Mental Health"},{"key":"10.3233\/JAD-220810_ref29","first-page":"S64","article-title":"Applying feedback from an advisory board of research participants to improve clinical trials in Alzheimer\u2019s disease and related dementias","volume":"7","author":"Walter","year":"2020","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-220810_ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2017.2954","article-title":"Comprehension of an elevated amyloid positron emission tomography biomarker result by cognitively normal older adults","volume":"75","author":"Mozersky","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220810_ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13195-018-0452-1","article-title":"Reactions to learning a \u201cnot elevated\u201d amyloid PET result in a preclinical Alzheimer\u2019s disease trial","volume":"10","author":"Grill","year":"2018","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:49Z","timestamp":1777370869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":26,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-220810","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]}}}